Malignant pleural effusion (MPE) is common and the management options
available for MPE are often limited. The key goal in the management of MPE is to
relieve patient’s symptoms with the least invasive means and in the most cost-effective
manner. The approach to the management of MPE should be tailored according to
patient’s overall prognosis, symptoms, functional status, social support, treatment
availability, and financial situation.
Pleurodesis has been the standard of care for the management of MPE for years and
talc continues to be the most effective sclerosant available for pleurodesis in MPE.
However, it is also associated with more invasive procedure and longer hospitalization.
Most clinical studies on MPE treatments in the past were focused on the creation of
successful pleurodesis in an attempt to stop reaccumulation of pleural fluid rather than
patient-related outcome measures (PROM). The current trend of incorporating
indwelling pleural catheter (IPC) in the management of MPE has been shown to be as
equally effective as talc pleurodesis with significantly fewer hospitalization days and
may be less costly compared to pleurodesis .
Keywords: Indwelling pleural catheter (IPC), Malignant Pleural Effusion (MPE),
Pleurodesis, Pleuroscopy, Thoracentesis, Thoracoscopy.
